General Medicine Archives - Pulmonology Advisor

General Medicine

Monkeypox and HIV Coinfection: Interim Guidance on Prevention and Treatment

By

Melissa I. Alvarez

October 6, 2022

Researchers evaluated potential treatment options for patients with HIV and monkeypox coinfection.

General Medicine

Evusheld Fact Sheet Updated With COVID-19 Risk Information

By

Brian Park, PharmD

October 6, 2022

Evusheld is a combination of 2 long-acting monoclonal antibodies designed to bind to distinct sites on the SARS-CoV-2 spike protein.

General Medicine

COVID-19 Pandemic Tied to Burnout in Health Care Professionals

October 6, 2022

The COVID-19 pandemic is associated with higher burnout among health care professionals (HCPs), particularly patient-facing HCPs.

General Medicine

Omega-3 Fatty Acid Concentration Linked to Cognitive Function

October 6, 2022

In a predominantly middle-aged cohort, higher omega-3 fatty acid concentrations are associated with better brain structure and cognitive function.

General Medicine

CDC Drops COVID-19 Travel Advisories as Countries Stop Tracking Cases

October 6, 2022

The CDC is dropping its foreign travel advisories for COVID-19 due to the inability of accurately calculating health risks to travelers.

General Medicine

COVID-19 mRNA Vaccines Safe in Stable Patients With Myasthenia Gravis

By

Sheila Jacobs

October 5, 2022

Researchers sought to investigate the safety of mRNA-based 2-dose vaccination against SARS-CoV-2 in a group of patients with myasthenia gravis.

of onabotulinumtoxin A is a safe and effective treatment for oab

General Medicine

Infections Reported After Single Dose of Monkeypox Vaccine

October 5, 2022

Most cases of monkeypox that occur after vaccination with the modified Vaccinia Ankara-Bavarian Nordic vaccine (MVA-BN) occur within 14 days of receipt of the first dose.

NAR is a common and often overlooked disorder because of its many nonspecific symptoms, lack of diagnostic testing, and frequent coexistence with AR. Proper diagnosis of NAR requires a high level of suspicion. A careful review of the patient’s history is essential, and allergen testing should be conducted to rule out AR; however, positivity for AR does not exclude the presence of NAR. Once diagnosed, use of topical intranasal glucocorticoids and topical antihistamines has been shown to provide the greatest relief of symptoms across the NAR spectrum, but treatment should always be tailored to the patient’s specific symptoms. In many cases, multifaceted interventions that use pharmacologic and adjunct strategies, such as trigger avoidance, are necessary for optimal relief.

General Medicine

Topical Antibiotics Shorten Duration of Conjunctival Symptoms

October 5, 2022

For children with acute infective conjunctivitis, topical antibiotics are associated with a shorter duration of conjunctival symptoms.

Obstructive Lung Disease

Nodular Liver a Marker for Worse Outcomes in Cystic Fibrosis Liver Disease

By

Jessica Nye, PhD

October 4, 2022

Researchers sought to determine the long-term clinical outcomes in children with nodular liver in cystic fibrosis.

General Pulmonology

Inhaled, Systemic Glucocorticoid Use May Affect White Matter Integrity

By

Jessica Nye, PhD

October 4, 2022

Researchers sought to test the hypothesis that systemic and inhaled glucocorticoid use is associated with changes in graey matter volume and white matter microstructure.